Valuation: Gedeon Richter

Market Cap 2,198B 7.06B 6.2B 5.7B 5.31B 10.02B 671B 10.23B 68.59B 26.58B 329B 26.5B 25.92B 1,146B P/E 2026 *
8.42x
P/E 2027 * 7.72x
Enterprise Value 1,883B 6.05B 5.31B 4.89B 4.55B 8.59B 575B 8.76B 58.77B 22.77B 282B 22.7B 22.21B 982B EV / Sales 2026 *
1.98x
EV / Sales 2027 * 1.74x
Free-Float
72.87%
Yield 2026 *
5.15%
Yield 2027 * 5.51%
1 week+0.83%
Current month-5.27%
1 month-5.27%
3 months+10.49%
6 months+31.41%
Current year+31.41%
1 week 33
Extreme 33
34.94
1 month 32.5
Extreme 32.5
36.56
Manager TitleAgeSince
Chief Executive Officer 47 2017-10-31
Director of Finance/CFO - 2025-04-30
Chief Operating Officer - 2018-12-31
Director TitleAgeSince
Chairman 78 2016-12-31
Chairman 90 2024-02-29
Director/Board Member 65 2012-04-25
Change 5-day change 1-year change 3-year change Capi.($)
+0.59%+0.83%+36.34% - 7.05B
+0.20%-0.10%+11.37%+77.46% 47.26B
-1.30%-0.42%+49.14%+102.33% 35B
-0.59%+1.65%-3.27%+43.52% 12.52B
-0.31%-0.27%+12.05%+90.24% 11.74B
+3.09%-2.72%+29.46%+115.95% 8.67B
-0.84%+1.67%+51.89%-9.13% 6.9B
-1.92%-0.80%+23.27%+219.81% 6.58B
+7.24%+10.32%-27.74%+9.65% 5.23B
-2.20%+5.02%+30.05%+126.31% 4.52B
Average +0.37%+2.26%+21.26%+86.24% 15.38B
Weighted average by Cap. -0.08%+0.93%+23.17%+85.65%

Financials

2026 *2027 *
Net sales 952B 3.06B 2.68B 2.47B 2.3B 4.34B 291B 4.43B 29.7B 11.51B 143B 11.47B 11.23B 496B 1,024B 3.29B 2.89B 2.66B 2.47B 4.67B 312B 4.76B 31.94B 12.38B 153B 12.34B 12.07B 534B
Net income 259B 833M 731M 673M 627M 1.18B 79.21B 1.21B 8.1B 3.14B 38.88B 3.13B 3.06B 135B 286B 919M 807M 743M 692M 1.3B 87.35B 1.33B 8.93B 3.46B 42.88B 3.45B 3.38B 149B
Net Debt -315B -1.01B -887M -816M -761M -1.43B -96.03B -1.46B -9.82B -3.8B -47.14B -3.79B -3.71B -164B -421B -1.35B -1.19B -1.09B -1.02B -1.92B -129B -1.96B -13.15B -5.1B -63.14B -5.08B -4.97B -220B
Logo Gedeon Richter
Richter Gedeon Vegyeszeti Gyar Nyrt is a Hungary-based company engaged in the research, development, production and marketing and trade of pharmaceutical products. The Company’s business is structured into three segments: the Pharmaceuticals segment, which includes the companies that are involved in the Company’s core business, including research, development and production of pharmaceutical products; the Wholesale and retail segment covers distribution companies and pharmacies that are part of the sales network in various regional markets and, as such convey its products to consumers, and the Other segment presents all the other consolidated companies that provide marketing and sales support services. The Company’s subsidiaries include, among others, Gedeon Richter Romania SA, Gedeon Richter Polska Sp Z.o.o., and ZAO Gedeon Richter-RUS.
Employees
-
Date Price Change
26-07-01 34.34 +0.59%
26-06-30 €34.14 -0.47%
26-06-29 €34.30 -0.23%
26-06-26 €34.38 +0.29%
26-06-25 €34.28 +0.82%
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
12,050.00HUF
Average target price
12,931.29HUF
Spread / Average Target
+7.31%

Quarterly revenue - Rate of surprise